Informations techniques
Exploitant
ARROW GENERIQUES
Présentation
TERBUTALINE ARROW 5 mg/2 ml, solution pour inhalation par nébuliseur en récipient unidose
Boîte de 50 récipients unidoses de 2 ml (code CIP: 365 790-1)
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
yGHF3Dbxb3yMx1V4